Health committee  As my closing remark, I would go back to something the vice-chair just said, which is that the partnership with the Gates Foundation was to align with the enterprise's scientific strategic plan. I absolutely agree with her that it is urgent that every country in the world, along

Health committee  Thank you. The 2005 plan had six priorities, as you've indicated, one of which was manufacturing capacity. The other five--and I won't list all of them--included things like research, a clinical trials capacity, community engagement, intellectual property issues, and industrial

Health committee  That's a good question. Let me first put that in context, and it's partly in response to Mr. Dufour's question. Global funding for HIV/AIDS vaccines--so not HIV/AIDS, but vaccines--has dropped this past year by 10% because of the economic downturn, at a time when the scientific p

Health committee  I'm on a science lecture here.

Health committee  In general, the real challenge, and it's a nice challenge to have, is how do we build on the scientific progress that's been made, really, over the last two and a half years? Dr. Carver mentioned one, and I'll go into it for a moment for the committee, because I think it's illust

Health committee  I have two objectives here today, from the point of view of the enterprise. One is that we need a vaccine.

Health committee  I believe—and that's why I took this position—the best way for us as a country and as a planet is to work together, aligned with a common strategic plan. Science changes. The world changes. What is true in 2010, fortunately, was not true in 2005. We have made progress, so we are

Health committee  I'll try to answer that. In the spirit of the original memorandum between the Government of Canada and the Gates Foundation--and I agree with you in terms of your impatience to move forward as quickly as possible--I would agree with you and support the notion that the funds cont

Health committee  Thank you very much, Madam Chair. My name is Alan Bernstein. I am the executive director of the Global HIV Vaccine Enterprise. Before that, I was the president of the Canadian Institutes of Health Research, and in that capacity I played a role, with a number of people, in actua